Radionuclide imaging in osteitis deformans
- PMID: 2196916
Radionuclide imaging in osteitis deformans
Abstract
New knowledge of osteoclastic function and new treatments to reduce osteolytic activity have combined to yield new degrees of biochemical control over the increased rate of bone resorption and formation that characterized osteitis deformans (OD; Paget's disease). We have briefly outlined current concepts, and provided an example of the role radionuclide imaging can play in delineating the skeletal areas involved in this disease.
Similar articles
-
UK guidelines on management of Paget's disease of bone.Rheumatology (Oxford). 2004 Mar;43(3):399-400. doi: 10.1093/rheumatology/keh037. Rheumatology (Oxford). 2004. PMID: 14963217 No abstract available.
-
[Bone scintigraphy of Paget's disease of bone (author's transl)].Rinsho Hoshasen. 1979 Dec;24(13):1521-2. Rinsho Hoshasen. 1979. PMID: 522285 Japanese. No abstract available.
-
Radiographs and scans in diagnosing symptomatic lesions of Paget's disease of bone (osteitis deformans).Geriatrics. 1974 Dec;29(12):49-54. Geriatrics. 1974. PMID: 4426511 No abstract available.
-
The role of bone scanning in Paget's disease.Metab Bone Dis Relat Res. 1981;3(4-5):243-54. doi: 10.1016/0221-8747(81)90040-0. Metab Bone Dis Relat Res. 1981. PMID: 6762482 Review.
-
Treatment of Paget's disease of bone (osteitis deformans) with sodium etidronate (EHDP).Clin Orthop Relat Res. 1977;(127):94-105. Clin Orthop Relat Res. 1977. PMID: 410576 Review. No abstract available.
Cited by
-
Diagnosis and treatment of Paget's disease of bone: position paper from the Italian Society of Osteoporosis, Mineral Metabolism and Skeletal Diseases (SIOMMMS).J Endocrinol Invest. 2024 Jun;47(6):1335-1360. doi: 10.1007/s40618-024-02318-1. Epub 2024 Mar 15. J Endocrinol Invest. 2024. PMID: 38488978 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Medical